BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28407516)

  • 1. Quantitative miR analysis in chronic lymphocytic leukaemia/small lymphocytic lymphoma - proliferation centres are characterized by high miR-92a and miR-155 and low miR-150 expression.
    Szurián K; Csala I; Piurkó V; Deák L; Matolcsy A; Reiniger L
    Leuk Res; 2017 Jul; 58():39-42. PubMed ID: 28407516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EZH2 is upregulated in the proliferation centers of CLL/SLL lymph nodes.
    Szurián K; Csala I; Marosvári D; Rajnai H; Dezső K; Bödör C; Piurkó V; Matolcsy A; Reiniger L
    Exp Mol Pathol; 2018 Oct; 105(2):161-165. PubMed ID: 30031020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC/miR-155 expression.
    Wang M; Tan LP; Dijkstra MK; van Lom K; Robertus JL; Harms G; Blokzijl T; Kooistra K; van T'veer MB; Rosati S; Visser L; Jongen-Lavrencic M; Kluin PM; van den Berg A
    J Pathol; 2008 May; 215(1):13-20. PubMed ID: 18348159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 expression by histiocytes may mimic cyclin D1-positive proliferation centres of chronic lymphocytic leukaemia/small lymphocytic lymphoma.
    Wu J; Zhang Y; Sun L; Zhai Q
    Pathol Res Pract; 2018 Jan; 214(1):72-75. PubMed ID: 29254788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT): A Characteristic Feature of DLBCL-RT and Potential Surrogate Marker for Clonal Relatedness.
    He R; Ding W; Viswanatha DS; Chen D; Shi M; Van Dyke D; Tian S; Dao LN; Parikh SA; Shanafelt TD; Call TG; Ansell SM; Leis JF; Mai M; Hanson CA; Rech KL
    Am J Surg Pathol; 2018 Jul; 42(7):843-854. PubMed ID: 29762141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferation centers in bone marrows involved by chronic lymphocytic leukemia/small lymphocytic lymphoma: a clinicopathologic analysis.
    Chang JC; Harrington AM; Olteanu H; VanTuinen P; Kroft SH
    Ann Diagn Pathol; 2016 Dec; 25():15-19. PubMed ID: 27806839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic lymphocytic leukemia with proliferation centers in bone marrow is associated with younger age at initial presentation, complex karyotype, and TP53 disruption.
    Garces S; Khoury JD; Kanagal-Shamanna R; Salem A; Wang SA; Ok CY; Hu S; Patel KP; Routbort MJ; Luthra R; Tang G; Schlette EJ; Bueso-Ramos CE; Medeiros LJ; Loghavi S
    Hum Pathol; 2018 Dec; 82():215-231. PubMed ID: 30086334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hsa-miR-15a and Hsa-miR-16-1 expression is not related to proliferation centers abundance and other prognostic factors in chronic lymphocytic leukemia.
    Rossi M; Fuligni F; Ciccone M; Agostinelli C; Righi S; Luciani M; Laginestra MA; Rigolin GM; Sapienza MR; Gazzola A; Mannu C; Cuneo A; Pileri S; Piccaluga PP
    Biomed Res Int; 2013; 2013():715391. PubMed ID: 24392455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences between chronic lymphocytic leukaemia and small lymphocytic lymphoma cells by proteomic profiling and SNP microarray analysis.
    Tooze JA; Hamzic E; Willis F; Pettengell R
    Cancer Genet; 2017 Dec; 218-219():20-38. PubMed ID: 29153094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The proliferation center microenvironment and prognostic markers in chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Soma LA; Craig FE; Swerdlow SH
    Hum Pathol; 2006 Feb; 37(2):152-9. PubMed ID: 16426914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low number of DNA copy number changes in small lymphocytic lymphoma.
    Autio K; Aalto Y; Franssila K; Elonen E; Joensuu H; Knuutila S
    Haematologica; 1998 Aug; 83(8):690-2. PubMed ID: 9793251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High rate of neoplastic cells with genetic abnormalities in proliferation centers of chronic lymphocytic leukemia.
    Balogh Z; Reiniger L; Rajnai H; Csomor J; Szepesi A; Balogh A; Deák L; Gagyi E; Bödör C; Matolcsy A
    Leuk Lymphoma; 2011 Jun; 52(6):1080-4. PubMed ID: 21417824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Most morphologic features in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) do not reliably predict underlying FISH genetics or immunoglobulin heavy chain variable region somatic mutational status.
    Garcia CF; Hunt KE; Kang H; Babb A; Gale JM; Vasef MA; Reichard KK
    Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):119-27. PubMed ID: 19826250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological and immunoglobulin VH gene analysis of interfollicular small lymphocytic lymphoma provides evidence for two types.
    Bahler DW; Aguilera NS; Chen CC; Abbondanzo SL; Swerdlow SH
    Am J Pathol; 2000 Oct; 157(4):1063-70. PubMed ID: 11021809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes simplex infection simulating Richter transformation: a series of four cases and review of the literature.
    Salem A; Loghavi S; Khoury JD; Agbay RL; Jorgensen JL; Medeiros LJ
    Histopathology; 2017 Apr; 70(5):821-831. PubMed ID: 27905140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant expression profile of miR-32, miR-98 and miR-374 in chronic lymphocytic leukemia.
    Rahimi Z; Ghorbani Z; Motamed H; Jalilian N
    Leuk Res; 2021 Dec; 111():106691. PubMed ID: 34455196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphotoxin beta expression is high in chronic lymphocytic leukemia but low in small lymphocytic lymphoma: a quantitative real-time reverse transcriptase polymerase chain reaction analysis.
    Nagy B; Ferrer A; Larramendy ML; Galimberti S; Aalto Y; Casas S; Vilpo J; Ruutu T; Vettenranta K; Franssila K; Knuutila S
    Haematologica; 2003 Jun; 88(6):654-8. PubMed ID: 12801841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small Lymphocytic Lymphoma: Analysis of Two Cohorts Including Patients in Clinical Trials of the German Chronic Lymphocytic Leukemia Study Group (GCLLSG) or in "Real-Life" Outside of Clinical Trials.
    Sachanas S; Pangalis GA; Fink AM; Bahlo J; Fischer K; Levidou G; Kyrtsonis MC; Bartzi V; Vassilakopoulos TP; Kalpadakis C; Koulieris E; Moschogiannis M; Yiakoumis X; Tsirkinidis P; Angelopoulou MK; Eichhorst B; Hallek M
    Anticancer Res; 2019 May; 39(5):2591-2598. PubMed ID: 31092457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL.
    Vasyutina E; Boucas JM; Bloehdorn J; Aszyk C; Crispatzu G; Stiefelhagen M; Breuer A; Mayer P; Lengerke C; Döhner H; Beutner D; Rosenwald A; Stilgenbauer S; Hallek M; Benner A; Herling M
    Leukemia; 2015 Oct; 29(10):2003-14. PubMed ID: 25936528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Small lymphocytic lymphoma/chronic lymphocytic leukemia with t(11;14)].
    Ueda K; Nakao M; Akano Y; Nomura K; Fujita Y; Okamoto T; Yokota S; Horiike S; Nakamura S; Taniwaki M
    Rinsho Ketsueki; 2001 Sep; 42(9):701-4. PubMed ID: 11680982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.